Argent Capital Management LLC Catalent, Inc. Transaction History

Argent Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$29.95 - $46.34 $618,078 - $956,318	-20,637 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$40.12 - $45.55 $68,645 - $77,936	1,711 Added 9.04%	20,637 $940,000
Q2 2018 Aug 09, 2018	BUY	$38.72 - $42.52 $128,550 - $141,166	3,320 Added 21.27%	18,926 $793,000
Q1 2018 May 03, 2018	BUY	$39.4 - $47.39 $4,531 - $5,449	115 Added 0.74%	15,606 $641,000
Q4 2017 Feb 14, 2018	BUY	$37.27 - $43.02 $142,371 - $164,336	3,820 Added 32.73%	15,491 $721,000
Q3 2017 Nov 15, 2017	BUY	$33.75 - $41.67 $393,896 - $486,330	11,671	11,671 $466,000

16.6M

10.7K

53.4K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Argent Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Argent Capital Management LLC with notifications on news.